Vitamin E found to bind cIAP1 and curb SMAC mimetic-driven cell death
- A screen flagged vitamin E as a suppressor of cell death triggered by TNF-α plus SMAC mimetics.
- It competes for the BIR3 domain of cIAP1, so the protein is not degraded and the RIPK1-dependent death complex does not form; antioxidant activity is not responsible.
- Binding was supported by several biophysical and cellular target-engagement assays.
- In a mouse colitis model, vitamin E eased disease while preserving cIAP1.
💡 Points Based on the abstract
The practical catch is interaction, not mechanism: if a dietary supplement can blunt a SMAC mimetic by occupying BIR3, patients on these agents are a real concern. Before trusting the colitis result, I'd want the dose and tissue exposure needed for cIAP1 engagement compared with what supplementation actually achieves, plus a non-binding tocopherol analog as a control.